Gallium Radioisotopes
Showing 1 - 25 of 121
Neuroendocrine Tumors Trial in Iowa City ([68Ga]Pentixafor)
Recruiting
- Neuroendocrine Tumors
-
Iowa City, IowaHolden Comprehensive Cancer Center
Mar 16, 2022
Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)
Recruiting
- Prostate Cancer Metastatic
-
Peking, ChinaPeking Union Medical College Hospital
Nov 25, 2022
Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-rosopatamb)
Not yet recruiting
- Metastatic Prostate Cancer
- 177Lu-DOTA-rosopatamb
- (no location specified)
Aug 29, 2022
Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)
Not yet recruiting
- Advanced Gastroenteropancreatic Neuroendocrine Tumor
- (no location specified)
Oct 16, 2023
Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)
Recruiting
- Neuroendocrine Tumors
- Gallium-68 NODAGA-JR11
-
Beijing, Beijing, China
- +1 more
Jul 27, 2022
Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)
Recruiting
- Meningioma
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 28, 2022
Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma Trial in Palo Alto (Gallium Ga 68 DOTA-NeoBOMB1, Gallium
Suspended
- Prostate Adenocarcinoma
- +2 more
- Gallium Ga 68 DOTA-NeoBOMB1
- Gallium Ga 68 PSMA-R2
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
May 3, 2022
Peri-Implantitis Trial in Van (Er, Cr: YSGG laser-assisted non-surgical mechanical therapy, Non-surgical mechanical therapy)
Completed
- Peri-Implantitis
- Er, Cr: YSGG laser-assisted non-surgical mechanical therapy
- Non-surgical mechanical therapy
-
Van, TurkeyNazli Zeynep Alpaslan
Sep 13, 2023
Neuroendocrine Tumors Trial in Beijing (Gallium-68 NODAGA-LM3 PET/CT, Gallium-68 DOTA-LM3 PET/CT, Gallium-68 DOTATATE PET/CT)
Completed
- Neuroendocrine Tumors
- Gallium-68 NODAGA-LM3 PET/CT
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Dec 20, 2021
Nontuberculous Mycobacterium Infection Trial in United States (Gallium nitrate)
Recruiting
- Nontuberculous Mycobacterium Infection
- Gallium nitrate
-
Birmingham, Alabama
- +8 more
Jan 10, 2023
Glioblastoma Trial in Milwaukee (Gallium maltolate (500 mg), Gallium maltolate (1,000 mg), Gallium maltolate (1,500 mg))
Recruiting
- Glioblastoma
- Gallium maltolate (500 mg)
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Sep 20, 2022
Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- 225^Ac-PSMA-617
- 68^Ga-PSMA-11
-
Darlinghurst, Australia
- +1 more
Nov 23, 2022
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed
Not yet recruiting
- Metastatic Prostate Carcinoma
- +4 more
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- CT (Computed Tomography)
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 3, 2022
Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography
Recruiting
- Hepatocellular Carcinoma
- Gallium Ga 68 Gozetotide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023
Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)
Not yet recruiting
- Cancer
- [177Lu]Lu-PSMA I&T
-
Meldola, Forlì, Italy
- +1 more
May 10, 2023
Diagnosis and Clinical Management of Angiogenic Breast Cancer Trial in Chandigarh, New Delhi, Johannesburg (Ga-68-PEG-?vß3-IAC
Not yet recruiting
- Diagnosis and Clinical Management of Angiogenic Breast Cancer
- Ga-68-PEG-Αvβ3-IAC PET/CT
-
Chandigarh, India
- +2 more
May 27, 2022
Semi-automated Segmentation Methods of SSTR PET for Dosimetry
Not yet recruiting
- Refractory Meningioma
- To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax
- (no location specified)
Sep 8, 2022
Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)
Completed
- Neuroendocrine Tumors
- +3 more
- 68Ga-DOTATOC PET/CT
-
Iowa City, IowaUniversity of Iowa Health Care
Jul 24, 2021
Endodontic Disease, Root Canal Infection Trial in Philadelphia (Waterlase Express™, BIOLASE®, Sodium Hypochlorite)
Not yet recruiting
- Endodontic Disease
- Root Canal Infection
- Waterlase Express™, BIOLASE®
- Sodium Hypochlorite
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, School of Dental Medicine
Jul 17, 2023
Healthy Volunteers, Pancreatic Ductal Adenocarcinoma Trial (RAD301 ([68Ga]-Trivehexin))
Not yet recruiting
- Healthy Volunteers
- Pancreatic Ductal Adenocarcinoma
- RAD301 ([68Ga]-Trivehexin)
- (no location specified)
Mar 22, 2023
Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)
Suspended
- Biochemically Recurrent Prostate Carcinoma
- Gallium Ga 68-labeled PSMA-11
- Positron Emission Tomography
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission
Recruiting
- Solid Tumors, Adult
- Metastatic Cancer
- Gallium-68 labelled (68Ga-) FAP-2286
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 1, 2022
Cancer Trial in Stanford (68Ga-FAPI, Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan)
Not yet recruiting
- Cancer
- 68Ga-FAPI
- +2 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 9, 2022
Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8 Trial in San Francisco (Angiogram,
Recruiting
- Prostate Adenocarcinoma
- +9 more
- Angiogram
- +3 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 5, 2022